Open AccessSulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections
Author(s) -
R Matthew Chico,
Enesia Banda Chaponda,
Cono Ariti,
Daniel Chandramohan
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix026
Subject(s) - medicine , odds ratio , adverse effect , malaria , sulfadoxine , sulfadoxine/pyrimethamine , chlamydia trachomatis , obstetrics , pregnancy , confidence interval , pyrimethamine , gynecology , immunology , plasmodium falciparum , biology , genetics
We conducted a prospective cohort study in Zambia among pregnant women who received intermittent preventive treatment using sulfadoxine-pyrimethamine (IPTp-SP).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom